Your browser doesn't support javascript.
loading
Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.
Mitjavila, Mercedes; Jimenez-Fonseca, Paula; Belló, Pilar; Pubul, Virginia; Percovich, Juan Carlos; Garcia-Burillo, Amparo; Hernando, Jorge; Arbizu, Javier; Rodeño, Emilia; Estorch, Montserrat; Llana, Belén; Castellón, Maribel; García-Cañamaque, Lina; Gajate, Pablo; Riesco, Maria Carmen; Miguel, Maria Begoña; Balaguer-Muñoz, David; Custodio, Ana; Cano, Juana María; Repetto, Alexandra; Garcia-Alonso, Pilar; Muros, Maria Angustias; Vercher-Conejero, Jose Luis; Carmona-Bayonas, Alberto.
Afiliação
  • Mitjavila M; Department of Nuclear Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
  • Jimenez-Fonseca P; Department of Medical Oncology, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.
  • Belló P; Department of Nuclear Medicine, Hospital Universitario La Fe, Valencia, Spain.
  • Pubul V; Department of Nuclear Medicine, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
  • Percovich JC; Department of Endocrinology and Nutrition, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Garcia-Burillo A; Department of Nuclear Medicine, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Hernando J; Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Arbizu J; Department of Nuclear Medicine, Clínica Universidad de Navarra, Pamplona, Spain.
  • Rodeño E; Department of Nuclear Medicine, Hospital Universitario de Cruces, Bilbao, Spain.
  • Estorch M; Department of Nuclear Medicine, Hospital de la Santa Creu i San Pau, Barcelona, Spain.
  • Llana B; Department of Nuclear Medicine, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Castellón M; Department of Nuclear Medicine, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
  • García-Cañamaque L; Department of Nuclear Medicine, Hospital HM Sanchinarro, Madrid, Spain.
  • Gajate P; Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Riesco MC; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Miguel MB; Department of Nuclear Medicine, Hospital Universitario de Burgos, Burgos, Spain.
  • Balaguer-Muñoz D; Department of Nuclear Medicine, Hospital Universitario Doctor Peset, Valencia, Spain.
  • Custodio A; Department of Medical Oncology, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain.
  • Cano JM; Department of Medical Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain.
  • Repetto A; Department of Nuclear Medicine, Hospital Universitario Son Espases, Mallorca, Spain.
  • Garcia-Alonso P; Department of Nuclear Medicine, Hospital Universitario de Getafe, Madrid, Spain.
  • Muros MA; Department of Nuclear Medicine, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Vercher-Conejero JL; Department of Nuclear Medicine-PET Unit, Hospital Universitario de Bellvitge - IDIBELL, Barcelona, Spain.
  • Carmona-Bayonas A; Department of Medical Oncology, Hospital Universitario Morales Meseguer, University de Murcia, IMIB, Murcia, Spain. alberto.carmonabayonas@gmail.com.
Eur J Nucl Med Mol Imaging ; 50(8): 2486-2500, 2023 07.
Article em En | MEDLINE | ID: mdl-36877234
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Paraganglioma / Feocromocitoma / Tumores Neuroendócrinos / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Paraganglioma / Feocromocitoma / Tumores Neuroendócrinos / Neoplasias das Glândulas Suprarrenais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article